Global AI-driven Drug Discovery Market Research Report 2026(Status and Outlook)
AI, its end-to-end drug discovery platform using generative artificial intelligence to discover new targets, design new molecules, and predict the outcome of clinical trials.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global AI-driven Drug Discovery market size was estimated at USD 825.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 10.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global AI-driven Drug Discovery market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global AI-driven Drug Discovery market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the AI-driven Drug Discovery market.
Global AI-driven Drug Discovery Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Entos
Selvita
Benevolent
Exscientia
Euretos
Illumina with AstraZeneca
Novo Nordisk with Microsoft
Iktos
Aqemia
Zephyr AI
Cyclicarx
Eli Lilly
Terray Therapeutics
Ardigen
ReviveMed
Insilico Medicine
XtalPi
MindRank
DP Technology
Market Segmentation (by Type)
Small Molecule Drug
Biological Modeling
Structural Biology
Others
Market Segmentation (by Application)
Pharmaceutical and Biotechnology Companies
Research Laboratories
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the AI-driven Drug Discovery Market
Overview of the regional outlook of the AI-driven Drug Discovery Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the AI-driven Drug Discovery Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of AI-driven Drug Discovery, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global AI-driven Drug Discovery market size was estimated at USD 825.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 10.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global AI-driven Drug Discovery market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global AI-driven Drug Discovery market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the AI-driven Drug Discovery market.
Global AI-driven Drug Discovery Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Entos
Selvita
Benevolent
Exscientia
Euretos
Illumina with AstraZeneca
Novo Nordisk with Microsoft
Iktos
Aqemia
Zephyr AI
Cyclicarx
Eli Lilly
Terray Therapeutics
Ardigen
ReviveMed
Insilico Medicine
XtalPi
MindRank
DP Technology
Market Segmentation (by Type)
Small Molecule Drug
Biological Modeling
Structural Biology
Others
Market Segmentation (by Application)
Pharmaceutical and Biotechnology Companies
Research Laboratories
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the AI-driven Drug Discovery Market
Overview of the regional outlook of the AI-driven Drug Discovery Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the AI-driven Drug Discovery Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of AI-driven Drug Discovery, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of AI-driven Drug Discovery
1.2 Key Market Segments
1.2.1 AI-driven Drug Discovery Segment by Type
1.2.2 AI-driven Drug Discovery Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 AI-DRIVEN DRUG DISCOVERY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global AI-driven Drug Discovery Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global AI-driven Drug Discovery Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 AI-DRIVEN DRUG DISCOVERY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global AI-driven Drug Discovery Product Life Cycle
3.3 Global AI-driven Drug Discovery Sales by Manufacturers (2020-2025)
3.4 Global AI-driven Drug Discovery Revenue Market Share by Manufacturers (2020-2025)
3.5 AI-driven Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global AI-driven Drug Discovery Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 AI-driven Drug Discovery Market Competitive Situation and Trends
3.8.1 AI-driven Drug Discovery Market Concentration Rate
3.8.2 Global 5 and 10 Largest AI-driven Drug Discovery Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 AI-DRIVEN DRUG DISCOVERY INDUSTRY CHAIN ANALYSIS
4.1 AI-driven Drug Discovery Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF AI-DRIVEN DRUG DISCOVERY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global AI-driven Drug Discovery Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to AI-driven Drug Discovery Market
5.7 ESG Ratings of Leading Companies
6 AI-DRIVEN DRUG DISCOVERY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global AI-driven Drug Discovery Sales Market Share by Type (2020-2025)
6.3 Global AI-driven Drug Discovery Market Size by Type (2020-2025)
6.4 Global AI-driven Drug Discovery Price by Type (2020-2025)
7 AI-DRIVEN DRUG DISCOVERY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global AI-driven Drug Discovery Market Sales by Application (2020-2025)
7.3 Global AI-driven Drug Discovery Market Size (M USD) by Application (2020-2025)
7.4 Global AI-driven Drug Discovery Sales Growth Rate by Application (2020-2025)
8 AI-DRIVEN DRUG DISCOVERY MARKET SALES BY REGION
8.1 Global AI-driven Drug Discovery Sales by Region
8.1.1 Global AI-driven Drug Discovery Sales by Region
8.1.2 Global AI-driven Drug Discovery Sales Market Share by Region
8.2 Global AI-driven Drug Discovery Market Size by Region
8.2.1 Global AI-driven Drug Discovery Market Size by Region
8.2.2 Global AI-driven Drug Discovery Market Size by Region
8.3 North America
8.3.1 North America AI-driven Drug Discovery Sales by Country
8.3.2 North America AI-driven Drug Discovery Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe AI-driven Drug Discovery Sales by Country
8.4.2 Europe AI-driven Drug Discovery Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific AI-driven Drug Discovery Sales by Region
8.5.2 Asia Pacific AI-driven Drug Discovery Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America AI-driven Drug Discovery Sales by Country
8.6.2 South America AI-driven Drug Discovery Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa AI-driven Drug Discovery Sales by Region
8.7.2 Middle East and Africa AI-driven Drug Discovery Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 AI-DRIVEN DRUG DISCOVERY MARKET PRODUCTION BY REGION
9.1 Global Production of AI-driven Drug Discovery by Region(2020-2025)
9.2 Global AI-driven Drug Discovery Revenue Market Share by Region (2020-2025)
9.3 Global AI-driven Drug Discovery Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America AI-driven Drug Discovery Production
9.4.1 North America AI-driven Drug Discovery Production Growth Rate (2020-2025)
9.4.2 North America AI-driven Drug Discovery Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe AI-driven Drug Discovery Production
9.5.1 Europe AI-driven Drug Discovery Production Growth Rate (2020-2025)
9.5.2 Europe AI-driven Drug Discovery Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan AI-driven Drug Discovery Production (2020-2025)
9.6.1 Japan AI-driven Drug Discovery Production Growth Rate (2020-2025)
9.6.2 Japan AI-driven Drug Discovery Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China AI-driven Drug Discovery Production (2020-2025)
9.7.1 China AI-driven Drug Discovery Production Growth Rate (2020-2025)
9.7.2 China AI-driven Drug Discovery Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Entos
10.1.1 Entos Basic Information
10.1.2 Entos AI-driven Drug Discovery Product Overview
10.1.3 Entos AI-driven Drug Discovery Product Market Performance
10.1.4 Entos Business Overview
10.1.5 Entos SWOT Analysis
10.1.6 Entos Recent Developments
10.2 Selvita
10.2.1 Selvita Basic Information
10.2.2 Selvita AI-driven Drug Discovery Product Overview
10.2.3 Selvita AI-driven Drug Discovery Product Market Performance
10.2.4 Selvita Business Overview
10.2.5 Selvita SWOT Analysis
10.2.6 Selvita Recent Developments
10.3 Benevolent
10.3.1 Benevolent Basic Information
10.3.2 Benevolent AI-driven Drug Discovery Product Overview
10.3.3 Benevolent AI-driven Drug Discovery Product Market Performance
10.3.4 Benevolent Business Overview
10.3.5 Benevolent SWOT Analysis
10.3.6 Benevolent Recent Developments
10.4 Exscientia
10.4.1 Exscientia Basic Information
10.4.2 Exscientia AI-driven Drug Discovery Product Overview
10.4.3 Exscientia AI-driven Drug Discovery Product Market Performance
10.4.4 Exscientia Business Overview
10.4.5 Exscientia Recent Developments
10.5 Euretos
10.5.1 Euretos Basic Information
10.5.2 Euretos AI-driven Drug Discovery Product Overview
10.5.3 Euretos AI-driven Drug Discovery Product Market Performance
10.5.4 Euretos Business Overview
10.5.5 Euretos Recent Developments
10.6 Illumina with AstraZeneca
10.6.1 Illumina with AstraZeneca Basic Information
10.6.2 Illumina with AstraZeneca AI-driven Drug Discovery Product Overview
10.6.3 Illumina with AstraZeneca AI-driven Drug Discovery Product Market Performance
10.6.4 Illumina with AstraZeneca Business Overview
10.6.5 Illumina with AstraZeneca Recent Developments
10.7 Novo Nordisk with Microsoft
10.7.1 Novo Nordisk with Microsoft Basic Information
10.7.2 Novo Nordisk with Microsoft AI-driven Drug Discovery Product Overview
10.7.3 Novo Nordisk with Microsoft AI-driven Drug Discovery Product Market Performance
10.7.4 Novo Nordisk with Microsoft Business Overview
10.7.5 Novo Nordisk with Microsoft Recent Developments
10.8 Iktos
10.8.1 Iktos Basic Information
10.8.2 Iktos AI-driven Drug Discovery Product Overview
10.8.3 Iktos AI-driven Drug Discovery Product Market Performance
10.8.4 Iktos Business Overview
10.8.5 Iktos Recent Developments
10.9 Aqemia
10.9.1 Aqemia Basic Information
10.9.2 Aqemia AI-driven Drug Discovery Product Overview
10.9.3 Aqemia AI-driven Drug Discovery Product Market Performance
10.9.4 Aqemia Business Overview
10.9.5 Aqemia Recent Developments
10.10 Zephyr AI
10.10.1 Zephyr AI Basic Information
10.10.2 Zephyr AI AI-driven Drug Discovery Product Overview
10.10.3 Zephyr AI AI-driven Drug Discovery Product Market Performance
10.10.4 Zephyr AI Business Overview
10.10.5 Zephyr AI Recent Developments
10.11 Cyclicarx
10.11.1 Cyclicarx Basic Information
10.11.2 Cyclicarx AI-driven Drug Discovery Product Overview
10.11.3 Cyclicarx AI-driven Drug Discovery Product Market Performance
10.11.4 Cyclicarx Business Overview
10.11.5 Cyclicarx Recent Developments
10.12 Eli Lilly
10.12.1 Eli Lilly Basic Information
10.12.2 Eli Lilly AI-driven Drug Discovery Product Overview
10.12.3 Eli Lilly AI-driven Drug Discovery Product Market Performance
10.12.4 Eli Lilly Business Overview
10.12.5 Eli Lilly Recent Developments
10.13 Terray Therapeutics
10.13.1 Terray Therapeutics Basic Information
10.13.2 Terray Therapeutics AI-driven Drug Discovery Product Overview
10.13.3 Terray Therapeutics AI-driven Drug Discovery Product Market Performance
10.13.4 Terray Therapeutics Business Overview
10.13.5 Terray Therapeutics Recent Developments
10.14 Ardigen
10.14.1 Ardigen Basic Information
10.14.2 Ardigen AI-driven Drug Discovery Product Overview
10.14.3 Ardigen AI-driven Drug Discovery Product Market Performance
10.14.4 Ardigen Business Overview
10.14.5 Ardigen Recent Developments
10.15 ReviveMed
10.15.1 ReviveMed Basic Information
10.15.2 ReviveMed AI-driven Drug Discovery Product Overview
10.15.3 ReviveMed AI-driven Drug Discovery Product Market Performance
10.15.4 ReviveMed Business Overview
10.15.5 ReviveMed Recent Developments
10.16 Insilico Medicine
10.16.1 Insilico Medicine Basic Information
10.16.2 Insilico Medicine AI-driven Drug Discovery Product Overview
10.16.3 Insilico Medicine AI-driven Drug Discovery Product Market Performance
10.16.4 Insilico Medicine Business Overview
10.16.5 Insilico Medicine Recent Developments
10.17 XtalPi
10.17.1 XtalPi Basic Information
10.17.2 XtalPi AI-driven Drug Discovery Product Overview
10.17.3 XtalPi AI-driven Drug Discovery Product Market Performance
10.17.4 XtalPi Business Overview
10.17.5 XtalPi Recent Developments
10.18 MindRank
10.18.1 MindRank Basic Information
10.18.2 MindRank AI-driven Drug Discovery Product Overview
10.18.3 MindRank AI-driven Drug Discovery Product Market Performance
10.18.4 MindRank Business Overview
10.18.5 MindRank Recent Developments
10.19 DP Technology
10.19.1 DP Technology Basic Information
10.19.2 DP Technology AI-driven Drug Discovery Product Overview
10.19.3 DP Technology AI-driven Drug Discovery Product Market Performance
10.19.4 DP Technology Business Overview
10.19.5 DP Technology Recent Developments
11 AI-DRIVEN DRUG DISCOVERY MARKET FORECAST BY REGION
11.1 Global AI-driven Drug Discovery Market Size Forecast
11.2 Global AI-driven Drug Discovery Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe AI-driven Drug Discovery Market Size Forecast by Country
11.2.3 Asia Pacific AI-driven Drug Discovery Market Size Forecast by Region
11.2.4 South America AI-driven Drug Discovery Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of AI-driven Drug Discovery by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global AI-driven Drug Discovery Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of AI-driven Drug Discovery by Type (2026-2035)
12.1.2 Global AI-driven Drug Discovery Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of AI-driven Drug Discovery by Type (2026-2035)
12.2 Global AI-driven Drug Discovery Market Forecast by Application (2026-2035)
12.2.1 Global AI-driven Drug Discovery Sales (K Units) Forecast by Application
12.2.2 Global AI-driven Drug Discovery Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of AI-driven Drug Discovery
1.2 Key Market Segments
1.2.1 AI-driven Drug Discovery Segment by Type
1.2.2 AI-driven Drug Discovery Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 AI-DRIVEN DRUG DISCOVERY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global AI-driven Drug Discovery Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global AI-driven Drug Discovery Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 AI-DRIVEN DRUG DISCOVERY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global AI-driven Drug Discovery Product Life Cycle
3.3 Global AI-driven Drug Discovery Sales by Manufacturers (2020-2025)
3.4 Global AI-driven Drug Discovery Revenue Market Share by Manufacturers (2020-2025)
3.5 AI-driven Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global AI-driven Drug Discovery Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 AI-driven Drug Discovery Market Competitive Situation and Trends
3.8.1 AI-driven Drug Discovery Market Concentration Rate
3.8.2 Global 5 and 10 Largest AI-driven Drug Discovery Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 AI-DRIVEN DRUG DISCOVERY INDUSTRY CHAIN ANALYSIS
4.1 AI-driven Drug Discovery Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF AI-DRIVEN DRUG DISCOVERY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global AI-driven Drug Discovery Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to AI-driven Drug Discovery Market
5.7 ESG Ratings of Leading Companies
6 AI-DRIVEN DRUG DISCOVERY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global AI-driven Drug Discovery Sales Market Share by Type (2020-2025)
6.3 Global AI-driven Drug Discovery Market Size by Type (2020-2025)
6.4 Global AI-driven Drug Discovery Price by Type (2020-2025)
7 AI-DRIVEN DRUG DISCOVERY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global AI-driven Drug Discovery Market Sales by Application (2020-2025)
7.3 Global AI-driven Drug Discovery Market Size (M USD) by Application (2020-2025)
7.4 Global AI-driven Drug Discovery Sales Growth Rate by Application (2020-2025)
8 AI-DRIVEN DRUG DISCOVERY MARKET SALES BY REGION
8.1 Global AI-driven Drug Discovery Sales by Region
8.1.1 Global AI-driven Drug Discovery Sales by Region
8.1.2 Global AI-driven Drug Discovery Sales Market Share by Region
8.2 Global AI-driven Drug Discovery Market Size by Region
8.2.1 Global AI-driven Drug Discovery Market Size by Region
8.2.2 Global AI-driven Drug Discovery Market Size by Region
8.3 North America
8.3.1 North America AI-driven Drug Discovery Sales by Country
8.3.2 North America AI-driven Drug Discovery Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe AI-driven Drug Discovery Sales by Country
8.4.2 Europe AI-driven Drug Discovery Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific AI-driven Drug Discovery Sales by Region
8.5.2 Asia Pacific AI-driven Drug Discovery Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America AI-driven Drug Discovery Sales by Country
8.6.2 South America AI-driven Drug Discovery Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa AI-driven Drug Discovery Sales by Region
8.7.2 Middle East and Africa AI-driven Drug Discovery Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 AI-DRIVEN DRUG DISCOVERY MARKET PRODUCTION BY REGION
9.1 Global Production of AI-driven Drug Discovery by Region(2020-2025)
9.2 Global AI-driven Drug Discovery Revenue Market Share by Region (2020-2025)
9.3 Global AI-driven Drug Discovery Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America AI-driven Drug Discovery Production
9.4.1 North America AI-driven Drug Discovery Production Growth Rate (2020-2025)
9.4.2 North America AI-driven Drug Discovery Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe AI-driven Drug Discovery Production
9.5.1 Europe AI-driven Drug Discovery Production Growth Rate (2020-2025)
9.5.2 Europe AI-driven Drug Discovery Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan AI-driven Drug Discovery Production (2020-2025)
9.6.1 Japan AI-driven Drug Discovery Production Growth Rate (2020-2025)
9.6.2 Japan AI-driven Drug Discovery Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China AI-driven Drug Discovery Production (2020-2025)
9.7.1 China AI-driven Drug Discovery Production Growth Rate (2020-2025)
9.7.2 China AI-driven Drug Discovery Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Entos
10.1.1 Entos Basic Information
10.1.2 Entos AI-driven Drug Discovery Product Overview
10.1.3 Entos AI-driven Drug Discovery Product Market Performance
10.1.4 Entos Business Overview
10.1.5 Entos SWOT Analysis
10.1.6 Entos Recent Developments
10.2 Selvita
10.2.1 Selvita Basic Information
10.2.2 Selvita AI-driven Drug Discovery Product Overview
10.2.3 Selvita AI-driven Drug Discovery Product Market Performance
10.2.4 Selvita Business Overview
10.2.5 Selvita SWOT Analysis
10.2.6 Selvita Recent Developments
10.3 Benevolent
10.3.1 Benevolent Basic Information
10.3.2 Benevolent AI-driven Drug Discovery Product Overview
10.3.3 Benevolent AI-driven Drug Discovery Product Market Performance
10.3.4 Benevolent Business Overview
10.3.5 Benevolent SWOT Analysis
10.3.6 Benevolent Recent Developments
10.4 Exscientia
10.4.1 Exscientia Basic Information
10.4.2 Exscientia AI-driven Drug Discovery Product Overview
10.4.3 Exscientia AI-driven Drug Discovery Product Market Performance
10.4.4 Exscientia Business Overview
10.4.5 Exscientia Recent Developments
10.5 Euretos
10.5.1 Euretos Basic Information
10.5.2 Euretos AI-driven Drug Discovery Product Overview
10.5.3 Euretos AI-driven Drug Discovery Product Market Performance
10.5.4 Euretos Business Overview
10.5.5 Euretos Recent Developments
10.6 Illumina with AstraZeneca
10.6.1 Illumina with AstraZeneca Basic Information
10.6.2 Illumina with AstraZeneca AI-driven Drug Discovery Product Overview
10.6.3 Illumina with AstraZeneca AI-driven Drug Discovery Product Market Performance
10.6.4 Illumina with AstraZeneca Business Overview
10.6.5 Illumina with AstraZeneca Recent Developments
10.7 Novo Nordisk with Microsoft
10.7.1 Novo Nordisk with Microsoft Basic Information
10.7.2 Novo Nordisk with Microsoft AI-driven Drug Discovery Product Overview
10.7.3 Novo Nordisk with Microsoft AI-driven Drug Discovery Product Market Performance
10.7.4 Novo Nordisk with Microsoft Business Overview
10.7.5 Novo Nordisk with Microsoft Recent Developments
10.8 Iktos
10.8.1 Iktos Basic Information
10.8.2 Iktos AI-driven Drug Discovery Product Overview
10.8.3 Iktos AI-driven Drug Discovery Product Market Performance
10.8.4 Iktos Business Overview
10.8.5 Iktos Recent Developments
10.9 Aqemia
10.9.1 Aqemia Basic Information
10.9.2 Aqemia AI-driven Drug Discovery Product Overview
10.9.3 Aqemia AI-driven Drug Discovery Product Market Performance
10.9.4 Aqemia Business Overview
10.9.5 Aqemia Recent Developments
10.10 Zephyr AI
10.10.1 Zephyr AI Basic Information
10.10.2 Zephyr AI AI-driven Drug Discovery Product Overview
10.10.3 Zephyr AI AI-driven Drug Discovery Product Market Performance
10.10.4 Zephyr AI Business Overview
10.10.5 Zephyr AI Recent Developments
10.11 Cyclicarx
10.11.1 Cyclicarx Basic Information
10.11.2 Cyclicarx AI-driven Drug Discovery Product Overview
10.11.3 Cyclicarx AI-driven Drug Discovery Product Market Performance
10.11.4 Cyclicarx Business Overview
10.11.5 Cyclicarx Recent Developments
10.12 Eli Lilly
10.12.1 Eli Lilly Basic Information
10.12.2 Eli Lilly AI-driven Drug Discovery Product Overview
10.12.3 Eli Lilly AI-driven Drug Discovery Product Market Performance
10.12.4 Eli Lilly Business Overview
10.12.5 Eli Lilly Recent Developments
10.13 Terray Therapeutics
10.13.1 Terray Therapeutics Basic Information
10.13.2 Terray Therapeutics AI-driven Drug Discovery Product Overview
10.13.3 Terray Therapeutics AI-driven Drug Discovery Product Market Performance
10.13.4 Terray Therapeutics Business Overview
10.13.5 Terray Therapeutics Recent Developments
10.14 Ardigen
10.14.1 Ardigen Basic Information
10.14.2 Ardigen AI-driven Drug Discovery Product Overview
10.14.3 Ardigen AI-driven Drug Discovery Product Market Performance
10.14.4 Ardigen Business Overview
10.14.5 Ardigen Recent Developments
10.15 ReviveMed
10.15.1 ReviveMed Basic Information
10.15.2 ReviveMed AI-driven Drug Discovery Product Overview
10.15.3 ReviveMed AI-driven Drug Discovery Product Market Performance
10.15.4 ReviveMed Business Overview
10.15.5 ReviveMed Recent Developments
10.16 Insilico Medicine
10.16.1 Insilico Medicine Basic Information
10.16.2 Insilico Medicine AI-driven Drug Discovery Product Overview
10.16.3 Insilico Medicine AI-driven Drug Discovery Product Market Performance
10.16.4 Insilico Medicine Business Overview
10.16.5 Insilico Medicine Recent Developments
10.17 XtalPi
10.17.1 XtalPi Basic Information
10.17.2 XtalPi AI-driven Drug Discovery Product Overview
10.17.3 XtalPi AI-driven Drug Discovery Product Market Performance
10.17.4 XtalPi Business Overview
10.17.5 XtalPi Recent Developments
10.18 MindRank
10.18.1 MindRank Basic Information
10.18.2 MindRank AI-driven Drug Discovery Product Overview
10.18.3 MindRank AI-driven Drug Discovery Product Market Performance
10.18.4 MindRank Business Overview
10.18.5 MindRank Recent Developments
10.19 DP Technology
10.19.1 DP Technology Basic Information
10.19.2 DP Technology AI-driven Drug Discovery Product Overview
10.19.3 DP Technology AI-driven Drug Discovery Product Market Performance
10.19.4 DP Technology Business Overview
10.19.5 DP Technology Recent Developments
11 AI-DRIVEN DRUG DISCOVERY MARKET FORECAST BY REGION
11.1 Global AI-driven Drug Discovery Market Size Forecast
11.2 Global AI-driven Drug Discovery Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe AI-driven Drug Discovery Market Size Forecast by Country
11.2.3 Asia Pacific AI-driven Drug Discovery Market Size Forecast by Region
11.2.4 South America AI-driven Drug Discovery Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of AI-driven Drug Discovery by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global AI-driven Drug Discovery Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of AI-driven Drug Discovery by Type (2026-2035)
12.1.2 Global AI-driven Drug Discovery Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of AI-driven Drug Discovery by Type (2026-2035)
12.2 Global AI-driven Drug Discovery Market Forecast by Application (2026-2035)
12.2.1 Global AI-driven Drug Discovery Sales (K Units) Forecast by Application
12.2.2 Global AI-driven Drug Discovery Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global AI-driven Drug Discovery Market Size by Type (M USD)
Table 4. Global AI-driven Drug Discovery Market Size by Application
Table 5. AI-driven Drug Discovery Market Size Comparison by Region (M USD)
Table 6. Global AI-driven Drug Discovery Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global AI-driven Drug Discovery Sales Market Share by Manufacturers (2020-2025)
Table 8. Global AI-driven Drug Discovery Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global AI-driven Drug Discovery Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-driven Drug Discovery as of 2025)
Table 11. Global Market AI-driven Drug Discovery Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global AI-driven Drug Discovery Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. AI-driven Drug Discovery Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global AI-driven Drug Discovery Sales by Type (K Units)
Table 27. Global AI-driven Drug Discovery Market Size by Type (M USD)
Table 28. Global AI-driven Drug Discovery Sales (K Units) by Type (2020-2025)
Table 29. Global AI-driven Drug Discovery Sales Market Share by Type (2020-2025)
Table 30. Global AI-driven Drug Discovery Market Size (M USD) by Type (2020-2025)
Table 31. Global AI-driven Drug Discovery Market Share by Type (2020-2025)
Table 32. Global AI-driven Drug Discovery Price (USD/Unit) by Type (2020-2025)
Table 33. Global AI-driven Drug Discovery Sales (K Units) by Application
Table 34. Global AI-driven Drug Discovery Market Size by Application
Table 35. Global AI-driven Drug Discovery Sales by Application (2020-2025) & (K Units)
Table 36. Global AI-driven Drug Discovery Sales Market Share by Application (2020-2025)
Table 37. Global AI-driven Drug Discovery Market Size by Application (2020-2025) & (M USD)
Table 38. Global AI-driven Drug Discovery Market Share by Application (2020-2025)
Table 39. Global AI-driven Drug Discovery Sales Growth Rate by Application (2020-2025)
Table 40. Global AI-driven Drug Discovery Sales by Region (2020-2025) & (K Units)
Table 41. Global AI-driven Drug Discovery Sales Market Share by Region (2020-2025)
Table 42. Global AI-driven Drug Discovery Market Size by Region (2020-2025) & (M USD)
Table 43. Global AI-driven Drug Discovery Market Size by Region (2020-2025)
Table 44. North America AI-driven Drug Discovery Sales by Country (2020-2025) & (K Units)
Table 45. North America AI-driven Drug Discovery Market Size by Country (2020-2025) & (M USD)
Table 46. Europe AI-driven Drug Discovery Sales by Country (2020-2025) & (K Units)
Table 47. Europe AI-driven Drug Discovery Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific AI-driven Drug Discovery Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific AI-driven Drug Discovery Market Size by Region (2020-2025) & (M USD)
Table 50. South America AI-driven Drug Discovery Sales by Country (2020-2025) & (K Units)
Table 51. South America AI-driven Drug Discovery Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa AI-driven Drug Discovery Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa AI-driven Drug Discovery Market Size by Region (2020-2025) & (M USD)
Table 54. Global AI-driven Drug Discovery Production (K Units) by Region(2020-2025)
Table 55. Global AI-driven Drug Discovery Revenue (US$ Million) by Region (2020-2025)
Table 56. Global AI-driven Drug Discovery Revenue Market Share by Region (2020-2025)
Table 57. Global AI-driven Drug Discovery Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America AI-driven Drug Discovery Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe AI-driven Drug Discovery Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan AI-driven Drug Discovery Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China AI-driven Drug Discovery Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Entos Basic Information
Table 63. Entos AI-driven Drug Discovery Product Overview
Table 64. Entos AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Entos Business Overview
Table 66. Entos SWOT Analysis
Table 67. Entos Recent Developments
Table 68. Selvita Basic Information
Table 69. Selvita AI-driven Drug Discovery Product Overview
Table 70. Selvita AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Selvita Business Overview
Table 72. Selvita SWOT Analysis
Table 73. Selvita Recent Developments
Table 74. Benevolent Basic Information
Table 75. Benevolent AI-driven Drug Discovery Product Overview
Table 76. Benevolent AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Benevolent Business Overview
Table 78. Benevolent SWOT Analysis
Table 79. Benevolent Recent Developments
Table 80. Exscientia Basic Information
Table 81. Exscientia AI-driven Drug Discovery Product Overview
Table 82. Exscientia AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Exscientia Business Overview
Table 84. Exscientia Recent Developments
Table 85. Euretos Basic Information
Table 86. Euretos AI-driven Drug Discovery Product Overview
Table 87. Euretos AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Euretos Business Overview
Table 89. Euretos Recent Developments
Table 90. Illumina with AstraZeneca Basic Information
Table 91. Illumina with AstraZeneca AI-driven Drug Discovery Product Overview
Table 92. Illumina with AstraZeneca AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Illumina with AstraZeneca Business Overview
Table 94. Illumina with AstraZeneca Recent Developments
Table 95. Novo Nordisk with Microsoft Basic Information
Table 96. Novo Nordisk with Microsoft AI-driven Drug Discovery Product Overview
Table 97. Novo Nordisk with Microsoft AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Novo Nordisk with Microsoft Business Overview
Table 99. Novo Nordisk with Microsoft Recent Developments
Table 100. Iktos Basic Information
Table 101. Iktos AI-driven Drug Discovery Product Overview
Table 102. Iktos AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Iktos Business Overview
Table 104. Iktos Recent Developments
Table 105. Aqemia Basic Information
Table 106. Aqemia AI-driven Drug Discovery Product Overview
Table 107. Aqemia AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Aqemia Business Overview
Table 109. Aqemia Recent Developments
Table 110. Zephyr AI Basic Information
Table 111. Zephyr AI AI-driven Drug Discovery Product Overview
Table 112. Zephyr AI AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Zephyr AI Business Overview
Table 114. Zephyr AI Recent Developments
Table 115. Cyclicarx Basic Information
Table 116. Cyclicarx AI-driven Drug Discovery Product Overview
Table 117. Cyclicarx AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Cyclicarx Business Overview
Table 119. Cyclicarx Recent Developments
Table 120. Eli Lilly Basic Information
Table 121. Eli Lilly AI-driven Drug Discovery Product Overview
Table 122. Eli Lilly AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Eli Lilly Business Overview
Table 124. Eli Lilly Recent Developments
Table 125. Terray Therapeutics Basic Information
Table 126. Terray Therapeutics AI-driven Drug Discovery Product Overview
Table 127. Terray Therapeutics AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Terray Therapeutics Business Overview
Table 129. Terray Therapeutics Recent Developments
Table 130. Ardigen Basic Information
Table 131. Ardigen AI-driven Drug Discovery Product Overview
Table 132. Ardigen AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Ardigen Business Overview
Table 134. Ardigen Recent Developments
Table 135. ReviveMed Basic Information
Table 136. ReviveMed AI-driven Drug Discovery Product Overview
Table 137. ReviveMed AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. ReviveMed Business Overview
Table 139. ReviveMed Recent Developments
Table 140. Insilico Medicine Basic Information
Table 141. Insilico Medicine AI-driven Drug Discovery Product Overview
Table 142. Insilico Medicine AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Insilico Medicine Business Overview
Table 144. Insilico Medicine Recent Developments
Table 145. XtalPi Basic Information
Table 146. XtalPi AI-driven Drug Discovery Product Overview
Table 147. XtalPi AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. XtalPi Business Overview
Table 149. XtalPi Recent Developments
Table 150. MindRank Basic Information
Table 151. MindRank AI-driven Drug Discovery Product Overview
Table 152. MindRank AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. MindRank Business Overview
Table 154. MindRank Recent Developments
Table 155. DP Technology Basic Information
Table 156. DP Technology AI-driven Drug Discovery Product Overview
Table 157. DP Technology AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. DP Technology Business Overview
Table 159. DP Technology Recent Developments
Table 160. Global AI-driven Drug Discovery Sales Forecast by Region (2026-2035) & (K Units)
Table 161. Global AI-driven Drug Discovery Market Size Forecast by Region (2026-2035) & (M USD)
Table 162. North America AI-driven Drug Discovery Sales Forecast by Country (2026-2035) & (K Units)
Table 163. North America AI-driven Drug Discovery Market Size Forecast by Country (2026-2035) & (M USD)
Table 164. Europe AI-driven Drug Discovery Sales Forecast by Country (2026-2035) & (K Units)
Table 165. Europe AI-driven Drug Discovery Market Size Forecast by Country (2026-2035) & (M USD)
Table 166. Asia Pacific AI-driven Drug Discovery Sales Forecast by Region (2026-2035) & (K Units)
Table 167. Asia Pacific AI-driven Drug Discovery Market Size Forecast by Region (2026-2035) & (M USD)
Table 168. South America AI-driven Drug Discovery Sales Forecast by Country (2026-2035) & (K Units)
Table 169. South America AI-driven Drug Discovery Market Size Forecast by Country (2026-2035) & (M USD)
Table 170. Middle East and Africa AI-driven Drug Discovery Sales Forecast by Country (2026-2035) & (Units)
Table 171. Middle East and Africa AI-driven Drug Discovery Market Size Forecast by Country (2026-2035) & (M USD)
Table 172. Global AI-driven Drug Discovery Sales Forecast by Type (2026-2035) & (K Units)
Table 173. Global AI-driven Drug Discovery Market Size Forecast by Type (2026-2035) & (M USD)
Table 174. Global AI-driven Drug Discovery Price Forecast by Type (2026-2035) & (USD/Unit)
Table 175. Global AI-driven Drug Discovery Sales (K Units) Forecast by Application (2026-2035)
Table 176. Global AI-driven Drug Discovery Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global AI-driven Drug Discovery Market Size by Type (M USD)
Table 4. Global AI-driven Drug Discovery Market Size by Application
Table 5. AI-driven Drug Discovery Market Size Comparison by Region (M USD)
Table 6. Global AI-driven Drug Discovery Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global AI-driven Drug Discovery Sales Market Share by Manufacturers (2020-2025)
Table 8. Global AI-driven Drug Discovery Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global AI-driven Drug Discovery Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-driven Drug Discovery as of 2025)
Table 11. Global Market AI-driven Drug Discovery Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global AI-driven Drug Discovery Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. AI-driven Drug Discovery Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global AI-driven Drug Discovery Sales by Type (K Units)
Table 27. Global AI-driven Drug Discovery Market Size by Type (M USD)
Table 28. Global AI-driven Drug Discovery Sales (K Units) by Type (2020-2025)
Table 29. Global AI-driven Drug Discovery Sales Market Share by Type (2020-2025)
Table 30. Global AI-driven Drug Discovery Market Size (M USD) by Type (2020-2025)
Table 31. Global AI-driven Drug Discovery Market Share by Type (2020-2025)
Table 32. Global AI-driven Drug Discovery Price (USD/Unit) by Type (2020-2025)
Table 33. Global AI-driven Drug Discovery Sales (K Units) by Application
Table 34. Global AI-driven Drug Discovery Market Size by Application
Table 35. Global AI-driven Drug Discovery Sales by Application (2020-2025) & (K Units)
Table 36. Global AI-driven Drug Discovery Sales Market Share by Application (2020-2025)
Table 37. Global AI-driven Drug Discovery Market Size by Application (2020-2025) & (M USD)
Table 38. Global AI-driven Drug Discovery Market Share by Application (2020-2025)
Table 39. Global AI-driven Drug Discovery Sales Growth Rate by Application (2020-2025)
Table 40. Global AI-driven Drug Discovery Sales by Region (2020-2025) & (K Units)
Table 41. Global AI-driven Drug Discovery Sales Market Share by Region (2020-2025)
Table 42. Global AI-driven Drug Discovery Market Size by Region (2020-2025) & (M USD)
Table 43. Global AI-driven Drug Discovery Market Size by Region (2020-2025)
Table 44. North America AI-driven Drug Discovery Sales by Country (2020-2025) & (K Units)
Table 45. North America AI-driven Drug Discovery Market Size by Country (2020-2025) & (M USD)
Table 46. Europe AI-driven Drug Discovery Sales by Country (2020-2025) & (K Units)
Table 47. Europe AI-driven Drug Discovery Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific AI-driven Drug Discovery Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific AI-driven Drug Discovery Market Size by Region (2020-2025) & (M USD)
Table 50. South America AI-driven Drug Discovery Sales by Country (2020-2025) & (K Units)
Table 51. South America AI-driven Drug Discovery Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa AI-driven Drug Discovery Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa AI-driven Drug Discovery Market Size by Region (2020-2025) & (M USD)
Table 54. Global AI-driven Drug Discovery Production (K Units) by Region(2020-2025)
Table 55. Global AI-driven Drug Discovery Revenue (US$ Million) by Region (2020-2025)
Table 56. Global AI-driven Drug Discovery Revenue Market Share by Region (2020-2025)
Table 57. Global AI-driven Drug Discovery Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America AI-driven Drug Discovery Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe AI-driven Drug Discovery Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan AI-driven Drug Discovery Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China AI-driven Drug Discovery Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. Entos Basic Information
Table 63. Entos AI-driven Drug Discovery Product Overview
Table 64. Entos AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. Entos Business Overview
Table 66. Entos SWOT Analysis
Table 67. Entos Recent Developments
Table 68. Selvita Basic Information
Table 69. Selvita AI-driven Drug Discovery Product Overview
Table 70. Selvita AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Selvita Business Overview
Table 72. Selvita SWOT Analysis
Table 73. Selvita Recent Developments
Table 74. Benevolent Basic Information
Table 75. Benevolent AI-driven Drug Discovery Product Overview
Table 76. Benevolent AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. Benevolent Business Overview
Table 78. Benevolent SWOT Analysis
Table 79. Benevolent Recent Developments
Table 80. Exscientia Basic Information
Table 81. Exscientia AI-driven Drug Discovery Product Overview
Table 82. Exscientia AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Exscientia Business Overview
Table 84. Exscientia Recent Developments
Table 85. Euretos Basic Information
Table 86. Euretos AI-driven Drug Discovery Product Overview
Table 87. Euretos AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Euretos Business Overview
Table 89. Euretos Recent Developments
Table 90. Illumina with AstraZeneca Basic Information
Table 91. Illumina with AstraZeneca AI-driven Drug Discovery Product Overview
Table 92. Illumina with AstraZeneca AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Illumina with AstraZeneca Business Overview
Table 94. Illumina with AstraZeneca Recent Developments
Table 95. Novo Nordisk with Microsoft Basic Information
Table 96. Novo Nordisk with Microsoft AI-driven Drug Discovery Product Overview
Table 97. Novo Nordisk with Microsoft AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Novo Nordisk with Microsoft Business Overview
Table 99. Novo Nordisk with Microsoft Recent Developments
Table 100. Iktos Basic Information
Table 101. Iktos AI-driven Drug Discovery Product Overview
Table 102. Iktos AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Iktos Business Overview
Table 104. Iktos Recent Developments
Table 105. Aqemia Basic Information
Table 106. Aqemia AI-driven Drug Discovery Product Overview
Table 107. Aqemia AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Aqemia Business Overview
Table 109. Aqemia Recent Developments
Table 110. Zephyr AI Basic Information
Table 111. Zephyr AI AI-driven Drug Discovery Product Overview
Table 112. Zephyr AI AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Zephyr AI Business Overview
Table 114. Zephyr AI Recent Developments
Table 115. Cyclicarx Basic Information
Table 116. Cyclicarx AI-driven Drug Discovery Product Overview
Table 117. Cyclicarx AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Cyclicarx Business Overview
Table 119. Cyclicarx Recent Developments
Table 120. Eli Lilly Basic Information
Table 121. Eli Lilly AI-driven Drug Discovery Product Overview
Table 122. Eli Lilly AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Eli Lilly Business Overview
Table 124. Eli Lilly Recent Developments
Table 125. Terray Therapeutics Basic Information
Table 126. Terray Therapeutics AI-driven Drug Discovery Product Overview
Table 127. Terray Therapeutics AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Terray Therapeutics Business Overview
Table 129. Terray Therapeutics Recent Developments
Table 130. Ardigen Basic Information
Table 131. Ardigen AI-driven Drug Discovery Product Overview
Table 132. Ardigen AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. Ardigen Business Overview
Table 134. Ardigen Recent Developments
Table 135. ReviveMed Basic Information
Table 136. ReviveMed AI-driven Drug Discovery Product Overview
Table 137. ReviveMed AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. ReviveMed Business Overview
Table 139. ReviveMed Recent Developments
Table 140. Insilico Medicine Basic Information
Table 141. Insilico Medicine AI-driven Drug Discovery Product Overview
Table 142. Insilico Medicine AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Insilico Medicine Business Overview
Table 144. Insilico Medicine Recent Developments
Table 145. XtalPi Basic Information
Table 146. XtalPi AI-driven Drug Discovery Product Overview
Table 147. XtalPi AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. XtalPi Business Overview
Table 149. XtalPi Recent Developments
Table 150. MindRank Basic Information
Table 151. MindRank AI-driven Drug Discovery Product Overview
Table 152. MindRank AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. MindRank Business Overview
Table 154. MindRank Recent Developments
Table 155. DP Technology Basic Information
Table 156. DP Technology AI-driven Drug Discovery Product Overview
Table 157. DP Technology AI-driven Drug Discovery Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 158. DP Technology Business Overview
Table 159. DP Technology Recent Developments
Table 160. Global AI-driven Drug Discovery Sales Forecast by Region (2026-2035) & (K Units)
Table 161. Global AI-driven Drug Discovery Market Size Forecast by Region (2026-2035) & (M USD)
Table 162. North America AI-driven Drug Discovery Sales Forecast by Country (2026-2035) & (K Units)
Table 163. North America AI-driven Drug Discovery Market Size Forecast by Country (2026-2035) & (M USD)
Table 164. Europe AI-driven Drug Discovery Sales Forecast by Country (2026-2035) & (K Units)
Table 165. Europe AI-driven Drug Discovery Market Size Forecast by Country (2026-2035) & (M USD)
Table 166. Asia Pacific AI-driven Drug Discovery Sales Forecast by Region (2026-2035) & (K Units)
Table 167. Asia Pacific AI-driven Drug Discovery Market Size Forecast by Region (2026-2035) & (M USD)
Table 168. South America AI-driven Drug Discovery Sales Forecast by Country (2026-2035) & (K Units)
Table 169. South America AI-driven Drug Discovery Market Size Forecast by Country (2026-2035) & (M USD)
Table 170. Middle East and Africa AI-driven Drug Discovery Sales Forecast by Country (2026-2035) & (Units)
Table 171. Middle East and Africa AI-driven Drug Discovery Market Size Forecast by Country (2026-2035) & (M USD)
Table 172. Global AI-driven Drug Discovery Sales Forecast by Type (2026-2035) & (K Units)
Table 173. Global AI-driven Drug Discovery Market Size Forecast by Type (2026-2035) & (M USD)
Table 174. Global AI-driven Drug Discovery Price Forecast by Type (2026-2035) & (USD/Unit)
Table 175. Global AI-driven Drug Discovery Sales (K Units) Forecast by Application (2026-2035)
Table 176. Global AI-driven Drug Discovery Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of AI-driven Drug Discovery
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global AI-driven Drug Discovery Market Size (M USD), 2025-2035
Figure 5. Global AI-driven Drug Discovery Market Size (M USD) (2020-2035)
Figure 6. Global AI-driven Drug Discovery Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. AI-driven Drug Discovery Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global AI-driven Drug Discovery Product Life Cycle
Figure 13. AI-driven Drug Discovery Sales Share by Manufacturers in 2025
Figure 14. Global AI-driven Drug Discovery Revenue Share by Manufacturers in 2025
Figure 15. AI-driven Drug Discovery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market AI-driven Drug Discovery Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by AI-driven Drug Discovery Revenue in 2025
Figure 18. Industry Chain Map of AI-driven Drug Discovery
Figure 19. Global AI-driven Drug Discovery Market PEST Analysis
Figure 20. Global AI-driven Drug Discovery Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global AI-driven Drug Discovery Market Share by Type
Figure 27. Sales Market Share of AI-driven Drug Discovery by Type (2020-2025)
Figure 28. Sales Market Share of AI-driven Drug Discovery by Type in 2025
Figure 29. Market Share of AI-driven Drug Discovery by Type (2020-2025)
Figure 30. Market Share of AI-driven Drug Discovery by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global AI-driven Drug Discovery Market Share by Application
Figure 33. Global AI-driven Drug Discovery Sales Market Share by Application (2020-2025)
Figure 34. Global AI-driven Drug Discovery Sales Market Share by Application in 2025
Figure 35. Global AI-driven Drug Discovery Market Share by Application (2020-2025)
Figure 36. Global AI-driven Drug Discovery Market Share by Application in 2025
Figure 37. Global AI-driven Drug Discovery Sales Growth Rate by Application (2020-2025)
Figure 38. Global AI-driven Drug Discovery Sales Market Share by Region (2020-2025)
Figure 39. Global AI-driven Drug Discovery Market Size by Region (2020-2025)
Figure 40. North America AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America AI-driven Drug Discovery Sales Market Share by Country in 2024
Figure 43. North America AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America AI-driven Drug Discovery Market Size by Country in 2024
Figure 45. U.S. AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada AI-driven Drug Discovery Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada AI-driven Drug Discovery Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico AI-driven Drug Discovery Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico AI-driven Drug Discovery Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe AI-driven Drug Discovery Sales Market Share by Country in 2024
Figure 53. Europe AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe AI-driven Drug Discovery Market Size by Country in 2024
Figure 55. Germany AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific AI-driven Drug Discovery Sales and Growth Rate (K Units)
Figure 66. Asia Pacific AI-driven Drug Discovery Sales Market Share by Region in 2024
Figure 67. Asia Pacific AI-driven Drug Discovery Market Size by Region in 2024
Figure 68. China AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America AI-driven Drug Discovery Sales and Growth Rate (K Units)
Figure 79. South America AI-driven Drug Discovery Sales Market Share by Country in 2024
Figure 80. South America AI-driven Drug Discovery Market Size and Growth Rate (M USD)
Figure 81. South America AI-driven Drug Discovery Market Size by Country in 2024
Figure 82. Brazil AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa AI-driven Drug Discovery Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa AI-driven Drug Discovery Sales Market Share by Region in 2024
Figure 90. Middle East and Africa AI-driven Drug Discovery Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa AI-driven Drug Discovery Market Size by Region in 2024
Figure 92. Saudi Arabia AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global AI-driven Drug Discovery Production Market Share by Region (2020-2025)
Figure 103. North America AI-driven Drug Discovery Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe AI-driven Drug Discovery Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan AI-driven Drug Discovery Production (K Units) Growth Rate (2020-2025)
Figure 106. China AI-driven Drug Discovery Production (K Units) Growth Rate (2020-2025)
Figure 107. Global AI-driven Drug Discovery Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global AI-driven Drug Discovery Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global AI-driven Drug Discovery Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global AI-driven Drug Discovery Market Share Forecast by Type (2026-2035)
Figure 111. Global AI-driven Drug Discovery Sales Forecast by Application (2026-2035)
Figure 112. Global AI-driven Drug Discovery Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of AI-driven Drug Discovery
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global AI-driven Drug Discovery Market Size (M USD), 2025-2035
Figure 5. Global AI-driven Drug Discovery Market Size (M USD) (2020-2035)
Figure 6. Global AI-driven Drug Discovery Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. AI-driven Drug Discovery Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global AI-driven Drug Discovery Product Life Cycle
Figure 13. AI-driven Drug Discovery Sales Share by Manufacturers in 2025
Figure 14. Global AI-driven Drug Discovery Revenue Share by Manufacturers in 2025
Figure 15. AI-driven Drug Discovery Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market AI-driven Drug Discovery Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by AI-driven Drug Discovery Revenue in 2025
Figure 18. Industry Chain Map of AI-driven Drug Discovery
Figure 19. Global AI-driven Drug Discovery Market PEST Analysis
Figure 20. Global AI-driven Drug Discovery Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global AI-driven Drug Discovery Market Share by Type
Figure 27. Sales Market Share of AI-driven Drug Discovery by Type (2020-2025)
Figure 28. Sales Market Share of AI-driven Drug Discovery by Type in 2025
Figure 29. Market Share of AI-driven Drug Discovery by Type (2020-2025)
Figure 30. Market Share of AI-driven Drug Discovery by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global AI-driven Drug Discovery Market Share by Application
Figure 33. Global AI-driven Drug Discovery Sales Market Share by Application (2020-2025)
Figure 34. Global AI-driven Drug Discovery Sales Market Share by Application in 2025
Figure 35. Global AI-driven Drug Discovery Market Share by Application (2020-2025)
Figure 36. Global AI-driven Drug Discovery Market Share by Application in 2025
Figure 37. Global AI-driven Drug Discovery Sales Growth Rate by Application (2020-2025)
Figure 38. Global AI-driven Drug Discovery Sales Market Share by Region (2020-2025)
Figure 39. Global AI-driven Drug Discovery Market Size by Region (2020-2025)
Figure 40. North America AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America AI-driven Drug Discovery Sales Market Share by Country in 2024
Figure 43. North America AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America AI-driven Drug Discovery Market Size by Country in 2024
Figure 45. U.S. AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada AI-driven Drug Discovery Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada AI-driven Drug Discovery Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico AI-driven Drug Discovery Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico AI-driven Drug Discovery Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe AI-driven Drug Discovery Sales Market Share by Country in 2024
Figure 53. Europe AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe AI-driven Drug Discovery Market Size by Country in 2024
Figure 55. Germany AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific AI-driven Drug Discovery Sales and Growth Rate (K Units)
Figure 66. Asia Pacific AI-driven Drug Discovery Sales Market Share by Region in 2024
Figure 67. Asia Pacific AI-driven Drug Discovery Market Size by Region in 2024
Figure 68. China AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America AI-driven Drug Discovery Sales and Growth Rate (K Units)
Figure 79. South America AI-driven Drug Discovery Sales Market Share by Country in 2024
Figure 80. South America AI-driven Drug Discovery Market Size and Growth Rate (M USD)
Figure 81. South America AI-driven Drug Discovery Market Size by Country in 2024
Figure 82. Brazil AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa AI-driven Drug Discovery Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa AI-driven Drug Discovery Sales Market Share by Region in 2024
Figure 90. Middle East and Africa AI-driven Drug Discovery Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa AI-driven Drug Discovery Market Size by Region in 2024
Figure 92. Saudi Arabia AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa AI-driven Drug Discovery Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa AI-driven Drug Discovery Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global AI-driven Drug Discovery Production Market Share by Region (2020-2025)
Figure 103. North America AI-driven Drug Discovery Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe AI-driven Drug Discovery Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan AI-driven Drug Discovery Production (K Units) Growth Rate (2020-2025)
Figure 106. China AI-driven Drug Discovery Production (K Units) Growth Rate (2020-2025)
Figure 107. Global AI-driven Drug Discovery Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global AI-driven Drug Discovery Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global AI-driven Drug Discovery Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global AI-driven Drug Discovery Market Share Forecast by Type (2026-2035)
Figure 111. Global AI-driven Drug Discovery Sales Forecast by Application (2026-2035)
Figure 112. Global AI-driven Drug Discovery Market Share Forecast by Application (2026-2035)
